Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selection

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Henneges, Carsten ^a   Bullinger, Dino ^b   Fux, Richard ^b   Friese, Natascha ^b   Seeger, Harald ^b   Neubauer, Hans ^b   Laufer, Stefan ^c   Gleiter, Christoph H ^b   Schwab, Matthias ^b,d   Zell, Andreas ^a   Kammerer, Bernd ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Institute of Pharmacy   (Germany)

^d DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 RIBOSYL PYRIDINIUM; CYTIDINE; DIHYDROURIDINE; INOSINE; NUCLEOSIDE; PSEUDOURIDINE; RNA DERIVATIVE; UNCLASSIFIED DRUG; URIDINE; RNA;

ADULT; AFFINITY CHROMATOGRAPHY; AGED; ARTICLE; BIOINFORMATICS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; ION TRAP MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; NUCLEIC ACID ANALYSIS; PREDICTION; REPRODUCIBILITY; RNA METHYLATION; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; URINALYSIS; AGE DISTRIBUTION; ALGORITHM; BREAST TUMOR; ELECTROSPRAY MASS SPECTROMETRY; METABOLISM; METABOLOMICS; METHODOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING; PROGNOSIS; URINE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALGORITHMS; BREAST NEOPLASMS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; METABOLOMICS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RNA, NEOPLASM; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 65649117768     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-104     Document Type: Article

References (38)

1. World Health Organization (WHO), Causes of death 2008 http://www.who.int/ entity/healthinfo/statistics/bodgbddeathdalyestimates.xls
2. Khatcheressian JL Wolff AC Smith TJ Grunfeld E Muss HB Vogel VG Halberg F Somerfield MR Davidson NE American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting J Clin Oncol 2006, 24:5091-5097. 17033037
3. Garcia GA Goodenough-Lashua DM Mechanism of RNA-Modifying and -Editing Enzymes Modification and Editing of RNA Washington: American Society for Microbiology Grosjean H, Benne R first 1998, 1:135-168.
4. The RNA Modification Database 2008 http://library.med.utah.edu/RNAmods/
5. Schram KH Urinary nucleosides Mass Spectrom Rev 1998, 17:131-251. 10095827
6. Tormey DC Waalkes TP Gehrke CW Biological markers in breast carcinoma-clinical correlations with pseudouridine, N2, N2-dimethylguanosine, and 1-methylinosine J Surg Oncol 1980, 14:267-273. 7392649
7. Itoh K Konno T Sasaki T Ishiwata S Ishida N Misugaki M Relationship of urinary pseudouridine and 1-methyladenosine to activity of leukemia and lymphoma Clin Chim Acta 1992, 206:181-189. 1606704
8. Waalkes TP Abeloff MD Ettinger DS Woo KB Gehrke CW Kuo KC Borek E Modified ribonucleosides as biological markers for patients with small cell carcinoma of the lung Eur J Cancer Clin Oncol 1982, 18:1267-1274. 6299748
9. Kammerer B Frickenschmidt A Muller CE Laufer S Gleiter CH Liebich H Mass spectrometric identification of modified urinary nucleosides used as potential biomedical markers by LC-ITMS coupling Anal Bioanal Chem 2005, 382;1017-1026. 15906010
10. Dudley E El-Sharkawi S Games DE Newton RP Analysis of urinary nucleosides. I. Optimisation of high performance liquid chromatography/ electrospray mass spectrometry Rapid Commun Mass Spectrom 2000, 14:1200-1207. 10918368
11. Bullinger D Frickenschmidt A Pelzing M Zey T Zurek G Laufer S Kammerer B Identification of urinary nucleosides by ESI-TOF-MS LC-GC Europe 2005, 5:16-17.
12. Kammerer B Frickenschmidt A Gleiter CH Laufer S Liebich H MALDI-TOF MS analysis of urinary nucleosides J Am Soc Mass Spectrom 2005, 16:940-947. 15907708
13. Bullinger D Fux R Nicholson G Plontke S Belka C Laufer S Gleiter CH Kammerer B Identification of urinary modified nucleosides an ribosylated metbaolites in humans via combined ESI-FTICR MS and ESI-IT MS analysis J Am Soc Mass Spectrom 2008, 19:1500-1513. 18657436
14. Yang J Xu G Zheng Y Kong H Pang T Lv S Yang Q Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases J Chromatogr B Analyt Technol Biomed Life Sci 2004, 813:59-65. 15556516
15. Seidel A Brunner S Seidel P Fritz GI Herbarth O Modified nucleosides: An accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control Br J Cancer 2006, 94:1726-1733. 16685264
16. Fujarewicz K Jarzab M Eszlinger M Krohn K Paschke R Oczko-Wojciechowska M Wiench M Kukulska A Jarzab B Swierniak A A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: Gene selection using support vector machines with bootstrapping Endocr Relat Cancer 2007, 14:809-826. 2216417 17914110
17. Oh JH Nandi A Gurnani P Knowles L Schorge J Rosenblatt KP Gao JX Proteomic biomarker identification for diagnosis of early relapse in ovarian cancer J Bioinform Comput Biol 2006, 4:1159-1179. 17245808
18. Denkert C Budczies J Kind T Weichert W Tablack P Sehouli J Niesporek S Konsgen D Dietel M Fiehn O Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors Cancer Res 2006, 66:10795-10804. 17108116
19. Mao Y Zhao X Wang S Cheng Y Urinary nucleosides based potential biomarker selection by support vector machine for bladder cancer recognition Anal Chim Acta 2007, 598:34-40. 17693304
20. Bullinger D Fröhlich H Klaus F Neubauer H Frickenschmidt A Henneges C Zell A Laufer S Gleiter CH Liebich H Kammerer B Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer Analytica Chimica Acta 2008, 618:29-34. 18501242
21. Frickenschmidt A Frohlich H Bullinger D Zell A Laufer S Gleiter CH Liebich H Kammerer B Metabonomics in cancer diagnosis: Mass spectrometry-based profiling of urinary nucleosides from breast cancer patients Biomarkers 2008, 13:435-449. 18484357
22. Duda R Hart P Stork G Pattern Classification New York: Wiley Interscience 2001
23. Somol P Pudil P Oscillating search algorithms for feature selection Proceedings of the International Conference on Pattern Recognition (ICPR'00) 2000, 2:406-409.
24. Guyon I Elisseeff A An Introduction into Variable and Feature Selection J Machine Learning Research 2003, 3:1157-1182.
25. Wasserman L All of nonparametric statistics New York: Springer Science and Business Media, LLC 2006
26. Chang CC Lin CJ LIBSVM: A library for support vector machines 2001 http://www.csie.ntu.edu.tw/~cjlin/libsvm
27. Mandel LR Hacker B Maag TA Altered transfer RNA methylase patterns in Marek's disease tumors Cancer Res 1971, 31:613-616. 4996578
28. Tsutsui E Srinivasan PR Borek E TRNA methylases in tumors of animal and human origin Proc Natl Acad Sci USA 1966, 56:1003-1009. 219961 4291222
29. Borek E Transfer RNA and transfer RNA modification in differentiation and neoplasia. Introduction Cancer Res 1971, 31:596-597. 5582119
30. Bullinger D Neubauer H Fehm T Laufer S Gleiter CH Kammerer B Metabolic signature of breast cancer cell line MCF-7: Profiling of modified nucleosides via LC-IT MS coupling BMC Biochem 2007, 8:25. 2219991 18047657
31. Fontecave M Atta M Mulliez E S-adenosylmethionine: Nothing goes to waste Trends Biochem Sci 2004, 29:243-249. 15130560
32. Kerr SJ Competing methyltransferase systems J Biol Chem 1972, 247:4248-4252. 4338482
33. Tormey DC Waalkes TP Kuo KC Gehrke CW Biologic markers in breast carcinoma: Clinical correlations with urinary polyamines Cancer 1980, 46:741-747. 7397636
34. Johansson Marcus JO Bystrom AS The Saccharomyces cerevisiae TAN1 gene is required for N4-acetylcytidine formation in tRNA RNA 2004, 10:712-719. 1370561 15037780
35. Thomale J Nass G Elevated urinary excretion of RNA catabolites as an early signal of tumor development in mice Cancer Lett 1982, 15:149-159. 6178502
36. La S Cho J Kim JH Kim KR Capillary electrophoretic profiling and pattern recognition analysis of urinary nucleosides from thyroid cancer patients Anal Chim Acta 2003, 486:171-182.
37. Constantinesco F Motorin Y Grosjean H Characterisation and enzymatic properties of tRNA(guanine 26, N (2), N (2))-dimethyltransferase (Trm1p) from Pyrococcus furiosus J Mol Biol 1999, 291:375-392. 10438627
38. Craddock VM Increased activity of transfer RNA N2-guanine dimethylase in tumors of liver and kidney Biochimica et Biophysica Acta, Nucleic Acids and Protein Synthesis 1972, 272:288-296.